Presentation TCT 2013 Cases III and IV: Left Main and Bifurcation Lesions Presenter: Bon-Kwon Koo October 31, 2013
Presentation TCT 2013 Can Basal Modalities Ever Be as Good as Hyperemic Indices? Presenter: Nils Johnson October 31, 2013
Presentation TCT 2013 Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data Presenter: Tim van de Hoef October 31, 2013
Presentation TCT 2013 Integrating IVUS and FFR into the Appropriate Use Criteria Presenter: Allen Jeremias October 30, 2013
Presentation TCT 2013 How I Integrate FFR and IVUS in the Cath Lab and Why Presenter: Soo-Jin Kang October 30, 2013
Presentation TCT 2013 HeartFlowNXT: A Prospective, Registry Evaluation of Noninvasive FFRCT vs. Invasive FFR Presenter: Bjarne N?rgaard October 30, 2013
Presentation TCT 2013 FFR in Patients with Previous Noninvasive Tests: How Do I Integrate Invasive and Noninvasive Assessment of Ischemia? Presenter: Morton Kern October 30, 2013
Presentation TCT 2013 Case Presentation: A Case Where I Needed Both IVUS and FFR Presenter: Justin Davies October 30, 2013
Presentation TCT 2013 Case #5: FFR Has an Important Role in Side Branch Stenting! Presenter: Indulis Kumsars October 30, 2013
Presentation TCT 2013 Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes Presenter: Michael Lim October 30, 2013
Presentation TCT 2013 FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease Presenter: Pim Tonino October 30, 2013
Presentation TCT 2013 FFR in Patients with Acute Coronary Syndromes Presenter: Habib Samady October 30, 2013
Presentation TCT 2013 FFR in Non-Left Main Bifurcation Lesions Presenter: Bon-Kwon Koo October 30, 2013
Presentation TCT 2013 FFR Clinical Trials: Review and Update Presenter: William Fearon October 30, 2013
Presentation TCT 2013 ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR Presenter: Javier Escaned October 30, 2013
News Industry News Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages October 30, 2013